585 related articles for article (PubMed ID: 25172243)
1. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Lim JP; Devaux J; Yuki N
Autoimmun Rev; 2014 Oct; 13(10):1070-8. PubMed ID: 25172243
[TBL] [Abstract][Full Text] [Related]
2. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
3. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies.
Doppler K; Appeltshauser L; Wilhelmi K; Villmann C; Dib-Hajj SD; Waxman SG; Mäurer M; Weishaupt A; Sommer C
J Neurol Neurosurg Psychiatry; 2015 Jul; 86(7):720-8. PubMed ID: 25694474
[TBL] [Abstract][Full Text] [Related]
4. [Antiganglioside antibodies in peripheral neuropathies].
Pardo J
Neurologia; 2001; 16(7):289-92. PubMed ID: 11485720
[No Abstract] [Full Text] [Related]
5. [Recent aspects of acute and chronic inflammatory polyneuropathies: Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
Pascual-Pascual SI
Rev Neurol; 2002 Aug 1-15; 35(3):269-76. PubMed ID: 12235589
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies.
Collet R; Caballero-Ávila M; Querol L
Rev Neurol (Paris); 2023 Oct; 179(8):831-843. PubMed ID: 36907709
[TBL] [Abstract][Full Text] [Related]
7. Guillain Barré syndrome and other immune mediated neuropathies: diagnosis and classification.
Eldar AH; Chapman J
Autoimmun Rev; 2014; 13(4-5):525-30. PubMed ID: 24434363
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies.
van der Meché FG; van Doorn PA
Ann Neurol; 1995 May; 37 Suppl 1():S14-31. PubMed ID: 8968214
[TBL] [Abstract][Full Text] [Related]
9. Immune-Mediated Neuropathies.
Gwathmey KG; Smith AG
Neurol Clin; 2020 Aug; 38(3):711-735. PubMed ID: 32703478
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
[TBL] [Abstract][Full Text] [Related]
11. Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies.
van Nes SI; Vanhoutte EK; van Doorn PA; Hermans M; Bakkers M; Kuitwaard K; Faber CG; Merkies IS
Neurology; 2011 Jan; 76(4):337-45. PubMed ID: 21263135
[TBL] [Abstract][Full Text] [Related]
12. Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy.
Tan CY; Yahya MA; Goh KJ; Shahrizaila N
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109705
[No Abstract] [Full Text] [Related]
13. Paranodal and other autoantibodies in chronic inflammatory neuropathies.
Querol L; Illa I
Curr Opin Neurol; 2015 Oct; 28(5):474-9. PubMed ID: 26263474
[TBL] [Abstract][Full Text] [Related]
14. Anti-ganglioside antibodies in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy in Chinese patients.
Fan C; Jin H; Hao H; Gao F; Sun Y; Lu Y; Liu Y; Lv P; Cui W; Teng Y; Huang Y
Muscle Nerve; 2017 Apr; 55(4):470-475. PubMed ID: 27464289
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in immune-mediated inflammatory neuropathies.
Martín-Aguilar L; Pascual-Goñi E; Querol L
Med Clin (Barc); 2019 Nov; 153(9):360-367. PubMed ID: 31443948
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of immune-mediated neuropathies].
Diószeghy P
Orv Hetil; 2011 Sep; 152(39):1560-8. PubMed ID: 21920842
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Kuwahara M; Suzuki S; Takada K; Kusunoki S
J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
[TBL] [Abstract][Full Text] [Related]
18. Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies.
Uncini A; Susuki K; Yuki N
Clin Neurophysiol; 2013 Oct; 124(10):1928-34. PubMed ID: 23639374
[TBL] [Abstract][Full Text] [Related]
19. Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
Miyaji K; Shahrizaila N; Umapathi T; Chan YC; Hirata K; Yuki N
Hum Immunol; 2014 Nov; 75(11):1089-91. PubMed ID: 25286001
[TBL] [Abstract][Full Text] [Related]
20. IL-8 as a potential biomarker in Guillain-Barre Syndrome.
Breville G; Lascano AM; Roux-Lombard P; Lalive PH
Eur Cytokine Netw; 2019 Dec; 30(4):130-134. PubMed ID: 32096474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
